NAFDAC Reports 70% Cut in Drug Imports, Boosts Local Manufacturing
The National Agency for Food and Drug Administration and Control (NAFDAC) has announced a significant shift in Nigeria's pharmaceutical industry, with local manufacturing of medicines improving from a 70:30 ratio of imports to locally produced drugs in 2019 to a projected 50:50 by 2025. This change is attributed to NAFDAC's 5+5 policy and Ceiling List initiative, which have restricted the importation of medicines that can be produced locally.
NAFDAC Director-General, Prof. Mojisola Adeyeye, revealed at the Lagos Chamber of Commerce and Industry’s Invest in Nigeria Conference and Expo 4.0 that the number of pharmaceutical manufacturing companies has increased from 174 to 190, while the importation of affected drug products has declined by 70%. The 5+5 policy, introduced in 2019, mandates companies to either establish production facilities in Nigeria or partner with local manufacturers.
As of June 2026, 176 pharmaceutical companies had undergone facility-layout review and approval by NAFDAC, contributing to a 25% increase in local manufacturing.
Plus234Feed summary based on reporting from Blueprint. Read the original report below.
Read full article
Continue on Blueprint
Enjoy this article?
Get the weekly Nigerian roundup — top stories, NPFL, naira. One email, Sunday morning.
Related Stories
NAFDAC Alerts on Local Production of Counterfeit Goods
Nigeria Aims for 70% Local Drug Production by 2026
NAFDAC DG Links Counterfeit Medicine Crisis to Gaps
NAFDAC Addresses Fake Product Concerns in Nigeria
FG Urged to Cut Energy Costs for Local Drug Production
NAFDAC Destroys N1.5tn Fake Products in Major Raids
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
